# Sionna Therapeutics, Inc.: Form SCHEDULE 13D, filed Feb 18, 2025

- Company: [Sionna Therapeutics, Inc.](/companies/sion.md) (CIK 2036042)
- Form: SCHEDULE 13D
- Filed: 2025-02-18
- Accepted by EDGAR: Feb 18, 2025, 16:22 ET
- Period: not reported
- Accession: 0001415889-25-004410
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2036042/000141588925004410/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2036042/000141588925004410/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2036042/000141588925004410/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-004410. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.